Connect Biopharma Holdings (CNTB) Total Liabilities (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Total Liabilities of $17.4 million for Q1 2026, up 23.75% sequentially from $14.1 million in Q4 2025, and up 78.24% YoY from $9.8 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Total Liabilities (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Total Liabilities for 7 years, with the latest figure at $17.4 million in Q1 2026.
- Quarterly Total Liabilities rose 78.24% year-over-year to $17.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.4 million (up 78.24% YoY) and the FY2025 annual result came in at $14.1 million, up 54.58% from the prior year.
- Total Liabilities improved to $17.4 million in Q1 2026 per CNTB's latest filing, from $14.1 million in the prior quarter.
- Over five years, Total Liabilities peaked at $25.9 million in Q4 2023 and troughed at $9.1 million in Q4 2024.
- A 5-year average of $14.8 million and a median of $14.1 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Liabilities plunged 64.77% in 2024, then jumped 78.24% in 2026.
- Over 5 years, Total Liabilities stood at $16.2 million in 2022, then soared by 59.96% to $25.9 million in 2023, then slumped by 64.77% to $9.1 million in 2024, then soared by 54.58% to $14.1 million in 2025, then climbed by 23.75% to $17.4 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $17.4 million, $14.1 million, and $12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 10.03 Bn |
| 10 | Connect Biopharma Holdings | 144.63 Mn | 144.63 Mn | - | 16.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.61 Mn |
| Mar 31, 2026 | 17.44 Mn |
| Dec 31, 2025 | 14.10 Mn |
| Sep 30, 2025 | 11.99 Mn |
| Jun 30, 2025 | 11.38 Mn |
| Mar 31, 2025 | 9.79 Mn |
| Dec 31, 2024 | 9.12 Mn |
| Jun 30, 2024 | 10.09 Mn |
| Dec 31, 2023 | 25.88 Mn |
| Jun 30, 2023 | 15.42 Mn |
| Dec 31, 2022 | 16.18 Mn |
| Jun 30, 2022 | 21.70 Mn |
| Dec 31, 2021 | 18.74 Mn |
| Dec 31, 2020 | 318.36 Mn |